Urofollitropin is a medication commonly used in infertility treatment to
stimulate the development of ovarian follicles. It is also known as
follicle-stimulating hormone (FSH), and is produced using recombinant DNA
technology.
The price of urofollitropin can vary depending on the brand, dosage, and
region. In the United States, a single vial of 75 IU can range from $200 to
$500. Patients undergoing fertility treatment may require multiple vials, which
can increase the overall cost.
In other countries, the cost of urofollitropin can be significantly
different. For example, in India, a single vial can cost around $30. This
difference in cost can be attributed to a variety of factors including
pharmaceutical regulations, production costs, and market demand.
Urofollitropin is typically administered by injection and requires careful
monitoring by a healthcare provider to prevent overstimulation of the ovaries.
Patients taking this medication may experience side effects such as headache,
nausea, and abdominal discomfort.
Despite the cost and potential side effects, urofollitropin can be an
effective treatment for infertility in women. It is important for patients to
discuss all options with their healthcare provider and consider the potential
benefits and risks before starting treatment.